#USA #ClorDiSys #Chlorine Dioxide #Branchburg #sterilization

ClorDiSys Solutions Expands Sterilization Capacity

ClorDiSys Solutions, LLC, a leading provider of chlorine dioxide-based contract sterilization, has recently announced a major expansion of its processing capabilities at its Branchburg, New Jersey facility. This strategic move is in response to the growing consumer demand for effective sterilization solutions, particularly in the medical and pharmaceutical sectors.

Doubling Sterilization Capacity

The expansion includes the addition of multiple sterilization chambers, effectively doubling the total available volume throughput to between 12 and 14 pallets per 24-hour period. With the upgraded facility working around the clock, ClorDiSys anticipates achieving a total weekly throughput of 80 to 100 pallets, allowing it to better serve an increasing number of clients seeking safe and reliable sterilization options.

In today's market, where efficiency and safety are paramount, chlorine dioxide has emerged as a superior alternative to traditional sterilization methods, such as ethylene oxide. Not only does chlorine dioxide provide quicker processing cycles, but it also operates at ambient temperature and is non-carcinogenic, making it ideal for a wide range of medical devices and complex products that may include electronics or batteries.

Innovative Chamber for R&D

In addition to the increased sterilization capacity, ClorDiSys has implemented a new 12-cubic-foot chamber dedicated to research and development purposes. This chamber will support an array of feasibility studies, proof-of-concept projects, and product validation for clients, catering to the heightened demand for innovative sterilization solutions.

Strengthening the Team

ClorDiSys is not only enhancing its equipment but also expanding its team to maintain high standards of quality and innovation. The company has recruited experienced specialists in quality assurance, validation engineering, operations, and business development. With this bolstered workforce, ClorDiSys ensures its commitment to exceeding customer expectations while fostering creativity and technological progress.

Mark Lecher, the CEO of ClorDiSys, commented on the expansion: "This is a significant milestone for ClorDiSys as the demand for effective sterilization solutions continues to soar. By doubling our capacity and investing in our team, we can provide timely solutions and accelerate innovation in the industries we serve."

About ClorDiSys

ClorDiSys Solutions is recognized for addressing complex sterilization challenges faced by medical device and pharmaceutical companies. The firm utilizes tried-and-true chlorine dioxide gas technology to unlock opportunities for innovation while reducing the risks associated with traditional sterilization methods. With the recent upgrades, ClorDiSys is better equipped to meet the evolving needs of its clientele, ensuring the highest levels of safety and effectiveness in sterilization.

For inquiries, potential clients can reach out to Emily Lorcheim at ClorDiSys, located at 50 Tannery Rd, Suite 1, Branchburg, NJ 08876. She can be contacted by phone at 908-236-4100 or via email at [email protected]